医薬品受託製造・調査サービス市場：サービスタイプ別、エンドユーザー別-2025-2030年の世界予測

医薬品受託製造・調査サービス市場の2024年の市場規模は1,950億9,000万米ドルで、2025年には2,148億7,000万米ドルに成長し、CAGRは10.55%、2030年には3,562億7,000万米ドルに達すると予測されています。

医薬品受託製造・調査サービスは、現代のヘルスケア・エコシステムにおける中心的な柱として台頭してきました。過去10年間、この分野は技術の進歩、規制環境の拡大、世界の健康需要の高まりに後押しされ、大きな変貌を遂げてきました。専門のコンサルタント会社から総合的な製造・研究機関まで、市場のプレーヤーは現在、かつてないほど機敏で革新的になっています。

最近の動向では、コスト管理、品質保証、医薬品開発期間の短縮といったプレッシャーの中で競争力を維持するため、企業は戦略の再調整を余儀なくされています。このダイナミックな状況により、企業は業務の合理化、プロセスの革新、デジタル統合の導入を迫られています。

この変革は業務的なものだけでなく、多くの企業の戦略的展望をも再構築しています。企業は、顧客や利害関係者により強固な成果をもたらすために、コンサルティング、製造、調査主導の洞察を統合したエンド・ツー・エンドのソリューションを追求しています。このような統合的アプローチにより、初期の創薬から臨床開発、最終的な製剤化、市場開拓に至るまで、製品ライフサイクルのあらゆる段階が最適化されます。

スピードと効率に対する要求が高まる中、製薬業界の利害関係者は、高度な製造技術と研究能力への投資を余儀なくされています。革新的な科学、厳格な規制、世界の市場からの圧力が相まって、医薬品業界では品質と性能に対する期待とベンチマークが再定義されています。

医薬品受託製造・調査サービス市場の変革

業界は、内部の進化と外部市場の力の両方によって推進されるパラダイムシフトを目の当たりにしています。デジタルトランスフォーメーション、自動化、人工知能は、生産ワークフローの再構築、エラーマージンの縮小、調査プロセスの迅速化において不可欠な役割を果たしています。組織が最先端のプロセス最適化ツールを採用するにつれ、データ分析の向上が予測的洞察とリアルタイムの意思決定を可能にしています。

安全性、品質、環境コンプライアンスに対する要求が進化しているため、企業は業務手法全体を再考する必要に迫られています。これに対応するため、多くの企業は、こうした新しい基準を満たすべく、サプライチェーンや生産エコシステムの大規模な見直しを進めています。この移行は業界の統合を加速させ、小規模なニッチプレーヤーと世界な大手企業との間にパートナーシップが生まれつつあります。今日見られるコラボレーションモデルは、効率性を高め、すべてのプロセスが厳格な規制要件に適合するようにするという共通のコミットメントを強調しています。

ニッチな能力のギャップを埋めるためにアウトソーシングされた機能を統合する企業が増えている一方で、既存企業はより高い品質とアウトプットの一貫性のために特注技術に投資することでポートフォリオを拡大しています。バイオテクノロジーとプロセス・エンジニアリングの急速な進歩により、この業界は岐路に立たされています。そこでは、従来のモデルが見直され、より総合的で患者中心の、テクノロジー主導の戦略が求められています。この変化は、最初の着想や研究から、最終製品の発見や調合に至るまで、あらゆる事業へのアプローチ方法を根本的に変えつつあります。

サービスおよびエンドユーザーにわたる主要なセグメンテーション洞察

市場の多面的な性質を理解するためには、サービスタイプのセグメンテーションの微妙な理解が不可欠です。サービスは、コンサルティングサービス、製造サービス、調査サービスに包括的に分類され、それぞれが独自のダイナミクスを持っています。コンサルティング・サービスでは、規制に関するコンサルティングと並んで、品質保証に関するコンサルティングに焦点を当てた研究が行われており、強固なコンプライアンス体制の重要性が強調されています。製造の分野では、原薬製造や生物製剤製造だけでなく、液剤、半固形製剤、固形製剤に細分化された最終製剤製造の複雑な細部からも洞察が引き出されています。この詳細な区分により、利害関係者は、製造工程や製剤タイプによって異なる特定の課題と機会をピンポイントで特定することができます。

調査サービスも同様に注目されています。これらのサービスは、生物学的分析評価、包括的な臨床研究事業、進歩的な創薬・前臨床研究分野、毒性学研究の専門分野をカバーしています。臨床研究サービスでは、第I相、第II相、第III相臨床試験を評価することで、さらなる細分化が達成されます。このような詳細なセグメンテーションは、研究イニシアチブの成熟度と焦点に基づいて、目標とする投資機会と戦略的優先順位を明らかにするのに役立ちます。

これと並行して、本市場調査ではエンドユーザー分析に基づくセグメンテーションを拡張し、学術・政府研究機関、バイオテクノロジー企業、大手製薬会社などの主要グループを調査しています。各顧客グループには、サービスの採用パターンに直接影響する明確なニーズと意思決定パラダイムがあります。このような多層的なセグメンテーションの枠組みにより、市場インサイトはサービス需要やエンドユーザーの期待の多様性を確実に捉え、業界の進化する情勢を包括的に捉えることができます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加と人口の高齢化により、契約製造サービスへの依存度が高まっている
    • 世界中でヘルスケア費と医薬品生産が増加
    • 生物製剤と個別化医療への重点化が医薬品調査の成長を促進
  • 抑制要因
    • アウトソーシングベンダーと製薬会社間の品質の不一致に関連するリスク
  • 機会
    • 医薬品の製造と調査における先進技術と自動化の統合
    • 製薬会社による研究開発への投資の増加は、契約サービスからの追加的なサポートを必要としています。
  • 課題
    • 国によって異なる規制基準
• 市場セグメンテーション分析
  • サービスタイプ：製造サービスへの嗜好増加
  • エンドユーザー：高度な技術と専門知識にアクセスするために、学術機関や政府の調査機関での採用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 医薬品受託製造・調査サービス市場：サービスタイプ別

• コンサルティングサービス
  • 品質保証コンサルティング
  • 規制コンサルティング
• 製造サービス
  • API製造
  • バイオ医薬品製造
  • 完成剤形の製造
    • 液体製剤
    • 半固体製剤
    • 固形製剤
• 調査サービス
  • バイオ分析サービス
  • 臨床調査サービス
    • フェーズI臨床試験
    • フェーズII臨床試験
    • フェーズIII臨床試験
  • 創薬
  • 前臨床調査
  • 毒性学研究

第7章 医薬品受託製造・調査サービス市場：エンドユーザー別

• 学術機関および政府調査機関
• バイオテクノロジー企業
• 製薬会社

第8章 南北アメリカの医薬品受託製造・調査サービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の医薬品受託製造・調査サービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの医薬品受託製造・調査サービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc
• Almac Group
• Amanta Healthcare Ltd.
• Aragen Life Sciences Ltd.
• Automatic Liquid Packaging Solutions LLC
• Baxter Pharmaceutical Solutions LLC
• Boehringer Ingelheim International GmbH
• Cambrex Corporation
• Catalent, Inc
• Curida AS
• Dalton Pharma Services
• Evonik Industries AG
• Famar Group
• Horizon Pharmaceuticals, Inc
• Laboratorios SALVAT, S.A
• Lonza Group Ltd.
• Nephron Pharmaceuticals Corporation
• Pfizer, Inc.
• Recipharm AB
• Rommelag SE & Co. KG
• Rusoma Laboratories Private Limited
• Silgan Unicep
• Unither Pharmaceuticals SAS
• UPM Pharmaceuticals, Inc.
• Woodstock Sterile Solutions

LIST OF FIGURES

• FIGURE 1. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET MULTI-CURRENCY
• FIGURE 2. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET MULTI-LANGUAGE
• FIGURE 3. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET RESEARCH PROCESS
• FIGURE 4. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 13. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 15. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 21. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY QUALITY ASSURANCE CONSULTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY API MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIOLOGICS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SEMI-AOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PHASE I CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PHASE II CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PHASE III CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 60. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 61. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 62. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 63. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 64. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 97. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 98. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 99. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 100. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 101. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 104. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 105. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 106. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 107. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 108. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 223. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 224. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 225. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 226. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 227. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 228. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CONSULTING SERVICES, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSAGE FORM MANUFACTURING, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-

The Pharmaceutical Contract Manufacturing & Research Services Market was valued at USD 195.09 billion in 2024 and is projected to grow to USD 214.87 billion in 2025, with a CAGR of 10.55%, reaching USD 356.27 billion by 2030.

Pharmaceutical contract manufacturing and research services have emerged as central pillars in the modern healthcare ecosystem. Over the past decade, this sector has experienced significant transformation fueled by technological advancements, an expanding regulatory environment, and rising global health demands. Market players, ranging from specialized consultancies to full-service manufacturing and research organizations, are now more agile and innovative than ever.

In recent years, companies have had to recalibrate their strategies in order to maintain competitiveness amidst pressures such as cost control, quality assurance, and accelerated drug development timelines. This dynamic landscape has prompted organizations to streamline operations, innovate processes, and embrace digital integration, all while adhering to ever-tightening regulatory frameworks.

The transformation is not just operational but is also reshaping the strategic outlook of many enterprises. Firms are pursuing end-to-end solutions that integrate consulting, manufacturing, and research-driven insights to deliver more robust outcomes for their clients and stakeholders. This integrated approach ensures that every stage of the product lifecycle is optimized-from early drug discovery and clinical development to final dosage formulation and market delivery.

With increasing demand for speed and efficiency, stakeholders across the pharmaceutical spectrum are compelled to invest in advanced manufacturing technologies and research capabilities. The confluence of innovative science, strict regulatory mandates, and global market pressures has redefined the expectations and benchmarks for quality and performance within the industry.

Transformative Shifts in the Pharmaceutical Manufacturing & Research Landscape

The industry is witnessing a paradigm shift driven by both internal evolution and external market forces. Digital transformation, automation, and artificial intelligence are playing essential roles in reengineering production workflows, reducing error margins, and expediting research processes. As organizations adopt state-of-the-art process optimization tools, improved data analytics are enabling predictive insights and real-time decision-making.

Regulatory bodies are also raising the bar; the evolving requirements for safety, quality, and environmental compliance are urging companies to reimagine their entire operational methodologies. In response, many organizations are undertaking major overhauls of their supply chain and production ecosystems in order to meet these new standards. This transition has accelerated industry consolidation, with partnerships emerging between smaller niche players and global giants. The collaboration models seen today highlight a shared commitment to enhancing efficiency and ensuring all processes comply with stringent regulatory requirements.

An increasing number of firms are integrating outsourced functionalities to fill gaps in niche capabilities, while established companies are expanding their portfolios by investing in bespoke technologies for higher quality and output consistency. Rapid advancements in biotechnology and process engineering have positioned the industry at a crossroads where traditional models are being revisited in favor of more holistic, patient-centric, and technology-driven strategies. This change is fundamentally altering how businesses approach everything from initial ideation and research to the discovery and formulation of finished products.

Key Segmentation Insights Across Services and End-Users

A nuanced understanding of service type segmentation is vital to appreciate the multifaceted nature of the market. The service landscape is comprehensively divided into consulting services, manufacturing services, and research services, each with its own unique dynamics. Under consulting services, there is a focused study on quality assurance consulting alongside regulatory consulting, emphasizing the critical need for robust compliance frameworks. In the manufacturing domain, insights are drawn not only from API manufacturing and biologics manufacturing, but also from the intricate details of finished dosage form manufacturing, further subdivided into liquid formulations, semi-solid formulations, and solid formulations. This in-depth segmentation allows stakeholders to pinpoint the specific challenges and opportunities that vary depending on the manufacturing process or formulation type.

Research services have been given equal measure of attention. These services cover bioanalytical assessments, comprehensive clinical research undertakings, the progressive fields of drug discovery and preclinical research, as well as the specialized area of toxicology studies. Within clinical research services, further granularity is achieved by evaluating phase I, phase II, and phase III clinical trials. Such detailed segmentation helps to elucidate targeted investment opportunities and strategic priorities based on the maturity and focus of research initiatives.

In parallel, the market study extends its segmentation based on end-user analysis, examining key groups such as academic and government research institutes, biotechnology companies, and large pharmaceutical companies. Each customer group has distinct needs and decision-making paradigms that directly influence service adoption patterns. This multi-layered segmentation framework ensures that market insights capture the diversity of service demands and end-user expectations, providing a comprehensive view of the industry's evolving landscape.

Based on Service Type, market is studied across Consulting Services, Manufacturing Services, and Research Services. The Consulting Services is further studied across Quality Assurance Consulting and Regulatory Consulting. The Manufacturing Services is further studied across API Manufacturing, Biologics Manufacturing, and Finished Dosage Form Manufacturing. The Finished Dosage Form Manufacturing is further studied across Liquid Formulations, Semi-Aolid Formulations, and Solid Formulations. The Research Services is further studied across Bioanalytical Services, Clinical Research Services, Drug Discovery, Preclinical Research, and Toxicology Studies. The Clinical Research Services is further studied across Phase I Clinical Trials, Phase II Clinical Trials, and Phase III Clinical Trials.

Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology Companies, and Pharmaceutical Companies.

Key Regional Insights Shaping Global Market Dynamics

Regional market dynamics play a crucial role in shaping the direction and pace of expansion in pharmaceutical contract manufacturing and research services. The Americas continue to be a crucial driver of growth, with North America embracing extensive investments in advanced research facilities and state-of-the-art manufacturing infrastructures. Meanwhile, the Europe, Middle East & Africa region showcases a rich blend of mature markets and emerging economies. This dynamic mix contributes to steady demand for high-quality services, driven by stringent regulatory requirements and a commitment to innovation in healthcare.

In the Asia-Pacific region, rapid industrialization coupled with increased investment in healthcare is opening up significant new opportunities. Emerging economies in this region are not only becoming key players in manufacturing but are also showing substantial progress in clinical research, driven by favorable government policies and a robust talent pool. Regional collaborations, strategic local partnerships, and a focus on cost-effective manufacturing are helping to cement the significance of Asia-Pacific in the global market. Collectively, these regional insights underscore the need for tailored strategies that address unique local market conditions while leveraging global best practices to drive sustainable growth.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation and Market Leadership

The competitive landscape in the pharmaceutical contract manufacturing and research arena is defined by an assembly of top-tier companies that have redefined industry benchmarks. Notable players such as AbbVie Inc and Almac Group set high standards through their persistent commitment to quality and innovation. Organizations like Amanta Healthcare Ltd. and Aragen Life Sciences Ltd. distinguish themselves through specialized service offerings and agile operational capabilities that cater to emerging market needs.

Additional leaders including Automatic Liquid Packaging Solutions LLC, Baxter Pharmaceutical Solutions LLC, and Boehringer Ingelheim International GmbH exemplify operational excellence and strategic foresight. Their robust portfolios, combined with investments in cutting-edge technologies, have enabled them to secure strong positions within the manufacturing sector. Companies such as Cambrex Corporation and Catalent, Inc further elevate industry standards by integrating advanced research capabilities with streamlined manufacturing processes. Curida AS and Dalton Pharma Services similarly enhance service excellence through their innovative approaches to regulatory adherence and quality management systems.

Other influential entities such as Evonik Industries AG, Famar Group, and Horizon Pharmaceuticals, Inc have expanded their global footprint by leveraging strategic partnerships and state-of-the-art production methodologies. Firms like Laboratorios SALVAT, S.A, Lonza Group Ltd., and Nephron Pharmaceuticals Corporation further illustrate the value of deep market expertise and operational agility. Industry benchmarks are continuously challenged by key players including Pfizer, Inc., Recipharm AB, and Rommelag SE & Co. KG. Emerging companies such as Rusoma Laboratories Private Limited, Silgan Unicep, Unither Pharmaceuticals SAS, UPM Pharmaceuticals, Inc., and Woodstock Sterile Solutions are also gaining prominence by combining local insights with international best practices, thus adding vibrancy and competitive depth to the market.

The report delves into recent significant developments in the Pharmaceutical Contract Manufacturing & Research Services Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc, Almac Group, Amanta Healthcare Ltd., Aragen Life Sciences Ltd., Automatic Liquid Packaging Solutions LLC, Baxter Pharmaceutical Solutions LLC, Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent, Inc, Curida AS, Dalton Pharma Services, Evonik Industries AG, Famar Group, Horizon Pharmaceuticals, Inc, Laboratorios SALVAT, S.A, Lonza Group Ltd., Nephron Pharmaceuticals Corporation, Pfizer, Inc., Recipharm AB, Rommelag SE & Co. KG, Rusoma Laboratories Private Limited, Silgan Unicep, Unither Pharmaceuticals SAS, UPM Pharmaceuticals, Inc., and Woodstock Sterile Solutions. Actionable Recommendations for Steering Market Growth

Leaders in the industry are advised to pursue innovation and develop integrated service portfolios that bridge consulting, manufacturing, and research. It is crucial to invest in automation, digitalization, and advanced analytics to drive consistent improvements in production efficiency and regulatory compliance. Companies should also expand their geographic footprints by establishing strategic alliances and leveraging local market expertise.

A key recommendation is to prioritize investments in research and development while seeking collaborative opportunities that blend academic excellence with industry experience. Engaging in strategic partnerships can not only bolster service capabilities but also mitigate operational risks. Furthermore, ensuring rigorous quality control and agile response systems to regulatory changes will be essential to maintaining competitive advantage in an increasingly complex environment. Emphasis on digital transformation is paramount, as the incorporation of data-driven strategies will refine decision-making processes and support sustained growth.

Conclusion Summarizing Strategic Insights and Market Evolution

The current landscape of pharmaceutical contract manufacturing and research services is marked by rapid innovation, strategic shifts, and evolving market segmentation. Technological advancements, changing regulatory requirements, and global market expansion continue to shape the industry's trajectory. By understanding the intricacies of service type and end-user segmentation, alongside recognizing key regional and corporate dynamics, stakeholders are better positioned to capitalize on emerging opportunities. Overall, strategic integration and agile operations remain the cornerstones of sustained market leadership.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic diseases and the aging population increasing reliance on contract manufacturing services
    • 5.1.1.2. Rising healthcare expenditure and pharmaceutical production worldwide
    • 5.1.1.3. Increasing emphasis on biologics and personalized medicine fuels growth in pharmaceutical research
  • 5.1.2. Restraints
    • 5.1.2.1. Risk associated with quality discrepancies between the outsourcing vendor and the pharmaceutical company
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of advanced technologies and automation in pharmaceutical manufacturing and research
    • 5.1.3.2. Increasing investments in research and development by pharmaceutical companies require additional support from contract services
  • 5.1.4. Challenges
    • 5.1.4.1. Varying regulatory standards across different countries
• 5.2. Market Segmentation Analysis
  • 5.2.1. Service Type: Increasing preference for manufacturing services
  • 5.2.2. End-User: Rising adoption in academic & government research institutes to access advanced technology and expertise
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pharmaceutical Contract Manufacturing & Research Services Market, by Service Type

• 6.1. Introduction
• 6.2. Consulting Services
  • 6.2.1. Quality Assurance Consulting
  • 6.2.2. Regulatory Consulting
• 6.3. Manufacturing Services
  • 6.3.1. API Manufacturing
  • 6.3.2. Biologics Manufacturing
  • 6.3.3. Finished Dosage Form Manufacturing
    • 6.3.3.1. Liquid Formulations
    • 6.3.3.2. Semi-Aolid Formulations
    • 6.3.3.3. Solid Formulations
• 6.4. Research Services
  • 6.4.1. Bioanalytical Services
  • 6.4.2. Clinical Research Services
    • 6.4.2.1. Phase I Clinical Trials
    • 6.4.2.2. Phase II Clinical Trials
    • 6.4.2.3. Phase III Clinical Trials
  • 6.4.3. Drug Discovery
  • 6.4.4. Preclinical Research
  • 6.4.5. Toxicology Studies

7. Pharmaceutical Contract Manufacturing & Research Services Market, by End-User

• 7.1. Introduction
• 7.2. Academic & Government Research Institutes
• 7.3. Biotechnology Companies
• 7.4. Pharmaceutical Companies

8. Americas Pharmaceutical Contract Manufacturing & Research Services Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Pharmaceutical Contract Manufacturing & Research Services Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing & Research Services Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2024
• 11.2. FPNV Positioning Matrix, 2024
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Oncimmune Holdings secures breakthrough USD 1.5 million contract
  • 11.3.2. Charles River and Gates Institute's strategic partnership advances CAR-T therapy production
  • 11.3.3. FAMAR and Lavipharm collaboration strengthens Greek pharmaceutical production
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc
• 2. Almac Group
• 3. Amanta Healthcare Ltd.
• 4. Aragen Life Sciences Ltd.
• 5. Automatic Liquid Packaging Solutions LLC
• 6. Baxter Pharmaceutical Solutions LLC
• 7. Boehringer Ingelheim International GmbH
• 8. Cambrex Corporation
• 9. Catalent, Inc
• 10. Curida AS
• 11. Dalton Pharma Services
• 12. Evonik Industries AG
• 13. Famar Group
• 14. Horizon Pharmaceuticals, Inc
• 15. Laboratorios SALVAT, S.A
• 16. Lonza Group Ltd.
• 17. Nephron Pharmaceuticals Corporation
• 18. Pfizer, Inc.
• 19. Recipharm AB
• 20. Rommelag SE & Co. KG
• 21. Rusoma Laboratories Private Limited
• 22. Silgan Unicep
• 23. Unither Pharmaceuticals SAS
• 24. UPM Pharmaceuticals, Inc.
• 25. Woodstock Sterile Solutions